{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Systematic Review of Histopathologic Surveys on Mucocutaneous Biopsies in Patients Developed COVID-19 Vaccine-Related Dermatologic Manifestations

Activity Steps

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the most common dermatologic reactions evolving after COVID vaccination.
  2. Describe several probable histopathologic findings associated with each clinical manifestation.
  3. Predict the severity of each lesion and propose the best clinical management for them.
  4. Compare post-COVID histopathologic findings with vaccine-related reactions and explain their most important differences.
Price: $15.00

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: AJD0123
Published: January 2023
Expires: 12/31/2024
Required Passing Score: 4/5 (80%)
Authors: Sadaf Salehi, MD, Sara Sadeghi, MD, Yasamin Kalantari, MD, and Azadeh Goodarzi, MD
Categories: Dermatology , Pathology
Topics: COVID-19